Sponsored by:

Nuclear Medicine: Page 136

Multiple FDG-PET/CT scans can influence lung cancer treatment
By Wayne Forrest
By showing how four or more follow-up FDG-PET/CT scans for lung cancer can alter patient treatment plans, researchers at Johns Hopkins University are making the case for expanded Medicare reimbursement for these exams in a new article in the February edition of the Journal of Nuclear Medicine.
February 19, 2015
2015 02 19 17 31 35 343 Petct Fifth Image Jnm 200
Foam rolling for sonographers; radiopharma market shows promise; mammo rates drop
By Brian Casey
February 16, 2015
Navidea highlights phase III Lymphoseek results
By AuntMinnie.com staff writers
Navidea Biopharmaceuticals is highlighting results published in the Annals of Surgical Oncology from a phase III clinical trial of its Lymphoseek radiopharmaceutical agent.
February 16, 2015
U.S. SPECT, PET radiopharma market shows promise amid challenges
By Wayne Forrest
Advances in neurological and cardiac imaging are expected to fuel sales growth in the SPECT and PET radiopharmaceutical markets in the U.S. in the second half of the decade, according to a new market research report from Bio-Tech Systems.
February 12, 2015
2015 02 12 17 29 35 546 Pet Amyvid Thumbnail 200
Canadian authorities tell McGill to fix nuc med safety issues
By AuntMinnie.com staff writers
The Canadian Nuclear Safety Commission has cited McGill University Health Centre in Montreal for deficiencies in its nuclear medicine department's radiation safety and worker training programs.
February 10, 2015
Capintec acquires Optility nuclear medicine software
By AuntMinnie.com staff writers
Energy measurement firm Capintec has acquired Optility software from Synergic Solutions.
February 10, 2015
Nuclear medicine physicians must change to survive
By Louise Gagnon
While nuclear medicine is not in imminent danger of extinction, it may need to reinvent itself for the future, according to the president of the British Nuclear Medicine Society. In particular, nuclear medicine physicians need to shed their self-image as purely imaging-based physicians to become more involved in clinical areas.
February 10, 2015
High cost tempers value of PET/MRI for cardiac lesions
By Wayne Forrest
The ability of FDG-PET/MRI to detail morphology and assess malignancy makes it a "powerful tool" for the diagnostic workup of cardiac tumors, but it should be used judiciously because of its high cost and limited availability, according to a new study from Germany in the February Journal of Nuclear Medicine.
February 9, 2015
2015 02 09 14 23 53 286 Ssfp Atrium Pet Mri Nensa 200
Canada may extend Chalk River license to 2018
By AuntMinnie.com staff writers
The government of Canada has recommended extending the production of molybdenum-99 through March 2018 at the National Research Universal reactor in Chalk River, Ontario.
February 8, 2015
CANM: Nuclear MPI tests could help ED docs rule out patients
By Louise Gagnon
The broader use of nuclear myocardial perfusion imaging (MPI) stress tests could help emergency department (ED) physicians better determine which patients can be safely discharged after a normal electrocardiogram and negative biomarker results, according to a February 1 talk at the Canadian Association of Nuclear Medicine (CANM) meeting in Montreal.
February 4, 2015
2014 02 11 15 10 50 886 Canadian Flag 200
Report: MBI adoption may hinge on cost
By AuntMinnie.com staff writers
Manufacturers must prove that molecular breast imaging (MBI) is a cost-effective adjunct to mammography if the breast cancer detection technology is to succeed, according to a new report from research and consulting firm GlobalData.
February 2, 2015
Navidea touts Lymphoseek research
By AuntMinnie.com staff writers
Navidea Biopharmaceuticals is highlighting clinical results regarding its Lymphoseek radiopharmaceutical that have been published in the Annals of Surgical Oncology.
January 28, 2015
Previous Page
Page 136 of 440
Next Page